Publication | Closed Access

High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma

Medicinal ChemistryPharmaceutical ScienceMedicineBioanalysisActive ProductAntitumor Agent TemozolomideHuman PlasmaAnti-cancer AgentLiquid ChromatographyDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistryChromatographyDrug Analysis